Clearance Summary
Vigilant Software Suite Vigilant Master Med received FDA 510(k) clearance under submission number K210075, sponsored by Fresenius Kabi AG. The device was reviewed via the Traditional premarket notification pathway and assigned to the General Hospital review panel. The statutory decision date of record is 2022-03-01.
- Submission: K210075
- Applicant / Sponsor: Fresenius Kabi AG
- Clearance pathway: Traditional
- Review panel: General Hospital
- Device class: Class II
- Regulation citation: 21 CFR 880.5725
- Decision date: 2022-03-01
Classification & Regulation
This clearance is catalogued under FDA product code PHC and 21 CFR 880.5725, within the General Hospital review panel as a Class II device.